SuperworthHWH International EPS ESYN
Diluted earnings per share by quarter and over the last twelve months, from 2022.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $0.03
- +200% on a year earlier
- Fiscal year 2023
- n/a
HWH International's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $0.03, up 200% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2023 | n/a | n/a |
| FY2022 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier |
|---|---|---|---|
| Q2 FY26 | $0.03 | +200% | |
| Q1 FY26 | −$0.08 | n/a | |
| Q2 FY25 | $0.01 | n/a | |
| Q1 FY25 | −$0.09 | n/a | |
| Q4 FY23 | −$0.45 | −1000% | |
| Q3 FY23 | −$0.20 | −500% | |
| Q4 FY22 | $0.05 | n/a | |
| Q3 FY22 | $0.05 | n/a | |
| Q1 FY22 | −$0.05 | n/a |
Against its peers
Companies in Healthcare nearest HWH International's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ESYNHWH International | n/m | |
| NEPHNephros | $0.16 | +33% a year |
| ATNMActinium Pharmaceuticals | $0.36 | |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| SPROSpero Therapeutics | $0.11 | |
| LFVNLifevantage | $0.40 | −46% a year |
| ICCCImmucell | $0.08 | −58% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| Peer median | $0.36 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on HWH International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.